¼¼°èÀÇ È­Çй߱¤ ¸é¿ªÃøÁ¤ ºÐ¼®±â ½ÃÀå º¸°í¼­(2025³â)
Chemiluminescence Immunoassay Analyzer Global Market Report 2025
»óǰÄÚµå : 1703112
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,426,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,288,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,150,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

È­Çй߱¤ ¸é¿ªÃøÁ¤ ºÐ¼®±â ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 6.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 79¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº Áø·á ÇöÀå¿¡¼­ÀÇ ½Å¼ÓÇϰí Á¤È®ÇÑ °á°ú¿¡ ´ëÇÑ ¼ö¿ä, ¼¼°è ÇコÄɾî ÁöÃâ Áõ°¡, °³ÀÎÈ­µÈ Ä¡·á Á¢±Ù ¹æ½Ä¿¡ ´ëÇÑ °ü½É, °í·ÉÈ­ Ãß¼¼, ¼¼°è ÇコÄÉ¾î ¼­ºñ½º Á¢±Ù¼º Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Áö¼Ó °¡´ÉÇÑ ºÐ¼®±â ±â¼ú, IT ¹× µ¥ÀÌÅÍ °ü¸® ¼Ö·ç¼ÇÀÇ µµÀÔ, ÀÇ·á ÀÎÇÁ¶ó °³¼±À» À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê, °³ÀÎÈ­µÈ Ä¡·á Á¢±Ù ¹æ½Ä¿¡ ´ëÇÑ °ü½É, °ËÃâ °¨µµ¿Í ÀÚµ¿È­ ±â´ÉÀÇ Áö¼ÓÀûÀÎ °³¼± µîÀÌ ÀÖ½À´Ï´Ù.

¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤ ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ Áõ°¡ ¿äÀÎÀ¸·Î´Â Àα¸ °í·ÉÈ­, °Ç°­¿¡ ÇØ·Î¿î »ýȰ ½À°ü, ±Þ¼º ÁúȯÀ» °¡Áø °³ÀÎÀÇ ¼ö¸íÀ» ¿¬ÀåÇϰí Àå±âÀûÀÎ °Ç°­ ¹®Á¦ÀÇ ¹ß»ý·üÀ» Áõ°¡½ÃŰ´Â ÀÇ·á ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù. È­Çй߱¤ ¸é¿ªÃøÁ¤ Àåºñ´Â ¹ÙÀÌ¿À¸¶Ä¿¸¦ Á¤È®ÇÏ°í ¹Î°¨ÇÏ°Ô °ËÃâÇÏ¿© Á¤È®ÇÑ Áø´Ü°ú Ä¡·á È¿°ú ¸ð´ÏÅ͸µ¿¡ µµ¿òÀ» ÁÜÀ¸·Î½á ¸¸¼ºÁúȯ °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹½ÉÀåÇÐȸ(American College of Cardiology)°¡ 2022³â 8¿ù¿¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â 2025³âºÎÅÍ 2060³â±îÁö ÁÖ¿ä ½ÉÇ÷°ü À§ÇèÀÎÀÚ°¡ Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ´ç´¢º´, ÀÌ»óÁöÁúÇ÷Áõ, °íÇ÷¾Ð, ºñ¸¸Àº ¸ðµÎ ÀÌ ±â°£ µ¿¾È Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â ¸¸¼º Áúȯ °ü¸®¿¡ ´ëÇÑ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ½À» °­Á¶ÇÕ´Ï´Ù.

È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤ ÀåÄ¡ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº ÀÇ»ç °áÁ¤ ¹× ºÐ¼® ´É·ÂÀ» °­È­Çϱâ À§ÇØ ÀÚµ¿ ºÐ¼®±â¿Í °°Àº ÷´Ü Áø´Ü ±â¼ú °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÚµ¿ ºÐ¼®±â´Â ºÐ¼® °úÁ¤À» ÀÚµ¿À¸·Î ¼öÇàÇÏ¿© °ËüÀÇ È¿À²ÀûÀ̰í Á¤È®ÇÑ °Ë»ç¸¦ À§ÇØ ÀÇ·á ½ÇÇè½Ç¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 7¿ù, Áß±¹ »ý¸í°úÇÐ ±â¾÷ Fapon Biotech Inc.´Â Shine i8000/9000 È­ÇÐ ¹ß±¤ ¸é¿ª ÃøÁ¤ ½Ã½ºÅÛÀ» ¹ßÇ¥ÇÏ¿´½À´Ï´Ù. ÀÌ °í¼Ó ÀüÀÚµ¿ ºÐ¼®±â´Â ½Ã°£´ç 900°ÇÀÇ Ãʰí󸮷®À¸·Î ÀÛµ¿Çϸç, ÆÄÆ®³Ê´Â ÃÖ÷´Ü ÀÓ»ó Áø´Ü ¼Ö·ç¼ÇÀ» °³¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. 10ºÐ ¸¸¿¡ Ãʱ⠰á°ú¸¦ ¾òÀ» ¼ö ÀÖ´Â ÀÌ ½Ã½ºÅÛÀº ½Ã°£ÀÌ Ã˹ÚÇÑ »óȲ¿¡¼­ ¸Å¿ì Áß¿äÇÑ ½Å¼ÓÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ºü¸¥ °Ë»ç ¼Óµµ¿Í ³ôÀº 󸮷®À¸·Î ´ë·®ÀÇ »ùÇÃÀ» È¿À²ÀûÀ¸·Î °ü¸®Çϸ鼭 ½Å·ÚÇÒ ¼ö ÀÖ´Â Á¤È®µµ¸¦ À¯ÁöÇÒ ¼ö ÀÖ¾î Áß´ëÇü °Ë»ç½Ç¿¡ ÀûÇÕÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Chemiluminescence immunoassay (CLIA) analyzers are sophisticated laboratory instruments used to detect and measure various substances such as proteins, hormones, and drugs in samples, employing chemiluminescence and immunoassay techniques. They are extensively utilized in clinical laboratories for their precise and automated detection capabilities, particularly for high-sensitivity detection of hormones, proteins, antibodies, and infectious agents.

The main types of CLIA analyzers include fully automated and semi-automated models. Fully automated CLIA analyzers are advanced devices that utilize chemiluminescence to automatically measure and analyze specific molecules in biological samples with high sensitivity and accuracy. They employ technologies such as sequential injection, random access, and batch analysis. These analyzers find applications in oncology, endocrinology, hepatitis and retroviruses, cardiac markers, infectious diseases, bone and mineral disorders, autoimmune diseases, allergies, gastrointestinal (GI) stool testing, and drug discovery and development. They are used by hospitals, clinics, medical laboratories, and pharmaceutical companies.

The chemiluminescence immunoassay analyzers market research report is one of a series of new reports from The Business Research Company that provides chemiluminescence immunoassay analyzers market statistics, including chemiluminescence immunoassay analyzers industry global market size, regional shares, competitors with a chemiluminescence immunoassay analyzers market share, detailed chemiluminescence immunoassay analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the chemiluminescence immunoassay analyzers industry. This chemiluminescence immunoassay analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chemiluminescence immunoassay analyzer market size has grown strongly in recent years. It will grow from $5.67 billion in 2024 to $6.08 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to ethical considerations and regulatory frameworks, adoption of risk management strategies in healthcare settings, shift towards patient-centered care models, integration of multiple diagnostic functionalities, and increasing emphasis on early detection of diseases.

The chemiluminescence immunoassay analyzer market size is expected to see strong growth in the next few years. It will grow to $7.93 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to the demand for rapid and accurate results at the point of care, rise in healthcare spending globally, focus on personalized treatment approaches, demographic trends towards an aging population, and increased access to healthcare services globally. Major trends in the forecast period include sustainable analyzer technologies, incorporation of it and data management solutions, government initiatives aimed at improving healthcare infrastructure, focus on personalized treatment approaches, and continuous improvements in detection sensitivity and automation capabilities.

The increasing prevalence of chronic diseases is expected to drive growth in the chemiluminescence immunoassay analyzer market in the coming years. Factors contributing to this rise include aging populations, unhealthy lifestyles, and advancements in medical care that extend the lifespan of individuals with acute conditions, thereby increasing the incidence of long-term health issues. Chemiluminescence immunoassay analyzers play a crucial role in managing chronic diseases by providing precise and sensitive detection of biomarkers, aiding in accurate diagnosis and monitoring of treatment effectiveness. For example, a report published by the American College of Cardiology in August 2022 projects significant increases in major cardiovascular risk factors in the United States from 2025 to 2060. Diabetes, dyslipidemia, hypertension, and obesity are all expected to rise substantially during this period, highlighting the growing demand for diagnostic tools in chronic disease management.

Leading companies in the chemiluminescence immunoassay analyzer market are focusing on developing advanced diagnostic technologies, such as automated analyzers, to enhance decision-making and analytical capabilities. Automated analyzers perform analytical processes automatically and are widely used in medical laboratories for efficient and accurate testing of samples. For instance, in July 2023, Fapon Biotech Inc., a China-based life sciences company, introduced the Shine i8000/9000 chemiluminescence immunoassay system. This high-speed, fully automated analyzer operates at an ultra-high throughput of 900 tests per hour, enabling partners to develop cutting-edge clinical diagnostic solutions. With initial results available in just 10 minutes, the system provides rapid insights crucial for time-sensitive situations. It boasts a rapid testing pace and high throughput capacity, efficiently managing large sample volumes while maintaining reliable accuracy, making it ideal for medium- to large-scale laboratories.

In November 2023, LASCCO, a Switzerland-based biotechnology company, and Abionic SA, also based in Switzerland, entered into a licensing agreement with Fapon, granting the company the rights to develop and commercialize the PSP (point-of-sample testing) technology. As part of the agreement, Fapon will integrate the PSP technology into its chemiluminescent immunoassay (CLIA) analyzer, with a focus on the Chinese market. Fapon Biotech is a China-based provider of comprehensive solutions in the in vitro diagnostics (IVD) industry.

Major companies operating in the chemiluminescence immunoassay analyzer market are F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Siemens Healthineers AG, Wiener Lab Group, PerkinElmer Inc., BioMerieux SA, Beckman Coulter Life Sciences, Tosoh Bioscience LLC, Sysmex Corporation, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., DiaSorin SpA, Euroimmun AG, Autobio Diagnostics Co. Ltd., Maccura Biotechnology Co. Ltd., Luminex Corporation, Fujirebio Holdings Inc., Randox Laboratories Ltd., Shenzhen Yhlo Biotech Co. Ltd., Addcare Bio-Tech Co. Ltd., Inova Diagnostics, Immunodiagnostic Systems Holdings (IDS), Dynex Technologies Inc., Nanjing Poclight Biotechnology Co. Ltd.

North America was the largest region in the chemiluminescence immunoassay analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemiluminescence immunoassay analyzer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chemiluminescence immunoassay analyzer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chemiluminescence immunoassay analyzer market consists of sales of pacifier thermometers, automated instrumentation, quality control materials, and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chemiluminescence Immunoassay Analyzer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chemiluminescence immunoassay analyzer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for chemiluminescence immunoassay analyzer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chemiluminescence immunoassay analyzer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Chemiluminescence Immunoassay Analyzer Market Characteristics

3. Chemiluminescence Immunoassay Analyzer Market Trends And Strategies

4. Chemiluminescence Immunoassay Analyzer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Chemiluminescence Immunoassay Analyzer Growth Analysis And Strategic Analysis Framework

6. Chemiluminescence Immunoassay Analyzer Market Segmentation

7. Chemiluminescence Immunoassay Analyzer Market Regional And Country Analysis

8. Asia-Pacific Chemiluminescence Immunoassay Analyzer Market

9. China Chemiluminescence Immunoassay Analyzer Market

10. India Chemiluminescence Immunoassay Analyzer Market

11. Japan Chemiluminescence Immunoassay Analyzer Market

12. Australia Chemiluminescence Immunoassay Analyzer Market

13. Indonesia Chemiluminescence Immunoassay Analyzer Market

14. South Korea Chemiluminescence Immunoassay Analyzer Market

15. Western Europe Chemiluminescence Immunoassay Analyzer Market

16. UK Chemiluminescence Immunoassay Analyzer Market

17. Germany Chemiluminescence Immunoassay Analyzer Market

18. France Chemiluminescence Immunoassay Analyzer Market

19. Italy Chemiluminescence Immunoassay Analyzer Market

20. Spain Chemiluminescence Immunoassay Analyzer Market

21. Eastern Europe Chemiluminescence Immunoassay Analyzer Market

22. Russia Chemiluminescence Immunoassay Analyzer Market

23. North America Chemiluminescence Immunoassay Analyzer Market

24. USA Chemiluminescence Immunoassay Analyzer Market

25. Canada Chemiluminescence Immunoassay Analyzer Market

26. South America Chemiluminescence Immunoassay Analyzer Market

27. Brazil Chemiluminescence Immunoassay Analyzer Market

28. Middle East Chemiluminescence Immunoassay Analyzer Market

29. Africa Chemiluminescence Immunoassay Analyzer Market

30. Chemiluminescence Immunoassay Analyzer Market Competitive Landscape And Company Profiles

31. Chemiluminescence Immunoassay Analyzer Market Other Major And Innovative Companies

32. Global Chemiluminescence Immunoassay Analyzer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chemiluminescence Immunoassay Analyzer Market

34. Recent Developments In The Chemiluminescence Immunoassay Analyzer Market

35. Chemiluminescence Immunoassay Analyzer Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â